The idiotype (Id) cascade in mice elicited the production of anti-R24 Id and anti-anti-Id monoclonal antibodies with antitumor and protective activity against human melanoma
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2010.01771.x/fullpdf
Reference60 articles.
1. Approaches to augmenting the immunogenicity of melanoma gangliosides: from whole melanoma cells to ganglioside-KLH conjugate vaccines;Livingston;Immunol Rev,1995
2. Increased tumor cell reactivity and complement-dependent cytotoxicity with mixtures of monoclonal antibodies against different gangliosides;Zhang;Cancer Immunol Immunother,1995
3. Carbohydrate antigens as targets for active specific immunotherapy;Ragupathi;Cancer Immunol Immunother,1996
4. Antibody inducing polyvalent cancer vaccines;Ragupathi;Cancer Treat Res,2005
5. GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody;Pukel;J Exp Med,1982
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Sialic acids and sialoglycoconjugates in cancer;Sialic Acids and Sialoglycoconjugates in the Biology of Life, Health and Disease;2020
2. Anti‐bevacizumab idiotype antibody vaccination is effective in inducing vascular endothelial growth factor‐binding response, impairing tumor outgrowth;Cancer Science;2016-04
3. Anti-Idiotypic Antibodies;Handbook of Therapeutic Antibodies;2014-08-12
4. Positioning Ganglioside D3 as an Immunotherapeutic Target in Lymphangioleiomyomatosis;The American Journal of Pathology;2013-07
5. Glycosylation of Glycolipids in Cancer: Basis for Development of Novel Therapeutic Approaches;Frontiers in Oncology;2013
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3